All results For patients For health professionals Medical encyclopedia News & articles Internet results

Drug images Click to enlarge

Forest submits sNDA to market Lexapro for treatment of generalized anxiety disorder
Forest submits sNDA to market Lexapro for treatment of generalized anxiety disorder NEW YORK, N.Y., November. 27, 2002 -- Forest Laboratories announced tat it has submitted a supplemental...
News & Articles (Drugs.com) · More like this

Forest Laboratories and Lundbeck announces positive results of Lexapro phase III study in adolescents with major depression
COPENHAGEN, Nov. 29, 2007-Forest Laboratories, Inc. and H. Lundbeck A/S today announced preliminary top-line results from a phase III study of Lexapro® (escitalopram oxalate) in the treatment of adolescents, aged 12-17, with Major Depressive Disorder (MDD). These results indicate that patients...
Clinical Trial Results (FDA) · More like this

Forest Laboratories Announces Federal Appeals Court Upholds Lexapro Patent Decision
...by the U.S. District Court for the District of Delaware which determined that the U.S. patent covering escitalopram, the active ingredient in Lexapro(R), is valid and upheld the injunction preventing Ivax/Teva's proposed generic product launch, thereby confirming Forest's and Lundbeck's patent...
News & Articles (Drugs.com) · More like this

Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro (escitalopram oxalate) ANDA Patent Litigation
...Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro® (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ('APA') transaction with Forest Laboratories, Inc. ('Forest') to acquire...
News & Articles (Drugs.com) · More like this

Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro (escitalopram oxalate) ANDA Patent Litigation
...-- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the settlement of the legal proceedings related to Lexapro(R) (escitalopram oxalate) tablets, it entered into an Asset Purchase Agreement with Forest Laboratories, Inc. ('Forest') to acquire several products...
News & Articles (Drugs.com) · More like this

See also: Anxiety, Bipolar Disorder, Depression, Fibromyalgia, Generalized Anxiety Disorder, Premenstrual Dysphoric Disorder, Vulvodynia

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.